shutterstock_728418352_casimiropt
casimiropt / Shutterstock.com
4 March 2019Americas

USITC to investigate Daewoong following Allergan complaint

The US International Trade Commission (ITC) has begun an investigation into  Daewoong Pharmaceuticals of South Korea and California-based  Evolus, following a complaint from Allergan.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
8 March 2019   The US International Trade Commission has instituted an investigation into certain blood separation and cell preparation devices.
Big Pharma
13 August 2019   Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.
Big Pharma
18 December 2020   The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.

More on this story

Medtech
8 March 2019   The US International Trade Commission has instituted an investigation into certain blood separation and cell preparation devices.
Big Pharma
13 August 2019   Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.
Big Pharma
18 December 2020   The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.

More on this story

Medtech
8 March 2019   The US International Trade Commission has instituted an investigation into certain blood separation and cell preparation devices.
Big Pharma
13 August 2019   Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.
Big Pharma
18 December 2020   The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.